Successful radiofrequency ablation in an infant with drug-resistant permanent junctional reciprocating tachycardia.
Over the past decade, the technique of radiofrequency ablation has evolved substantially. Currently, most forms of cardiac arrhythmias seen in children can be treated with good long-term results and low risk of adverse outcome. Curative arrhythmia treatment with this technique, however, is still uncommon in neonates and infants. Reported here is our experience in the management of an 8-week-old with drug-resistant permanent junctional reciprocating tachycardia.
Jaeggi
E
E
Adolph Basser Cardiac Institute, Royal Alexandra Hospital for Children, University of Sydney, New South Wales, Australia. Edgar.Jaeggi@hcuge.ch
Lau
K C
KC
Cooper
S G
SG
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D017115:Catheter Ablation; D004562:Electrocardiography; D006801:Humans; D007223:Infant; D013015:Sotalol / Q000627:therapeutic use; D013613:Tachycardia, Ectopic Junctional / Q000188:drug therapy / Q000628:therapy*; D017211:Treatment Failure
D000889:Anti-Arrhythmia Agents; D013015:Sotalol